INmune Bio Inc.

Symbol: NYSE: INMB
Market Cap: Private
Sector: Biotechnology
  • A novel strategy that treats Alzheimer’s disease as an immunologic, not neurologic disease.
  • Our goal is to remodel, repair and restore the aging brain to prevent cognitive decline, not to slow cognitive decline.
  • In Phase II clinical trials with top line data in 12 months